Regen BioPharma, Inc.
RGBP · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 0% | -0.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -220.1% | 26.4% | -716.2% | -549.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -283.2% | -32.8% | -871.9% | -446.2% |
| EPS Diluted | -0.007 | -0.001 | -0.065 | -0.064 |
| % Growth | -677.8% | 98.6% | -2.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |